Both in Pharmaceuticals
Ligand Pharmaceuticals vs Liquidia
Over the past year LGND returned +79.3% and LQDA returned +210.0%; their daily moves had a correlation of 0.16.
LGND +79.3% LQDA +210.0%Growth of $1, one year, split-adjusted
| Metric | LGND | LQDA |
|---|---|---|
| Price | $310.36 | $70.69 |
| Market cap | $6.19B | $6.33B |
| Today | −1.19% | −4.05% |
| 1 month | +10.6% | +4.4% |
| 6 months | +61.1% | +100.9% |
| Year to date | +64.2% | +105.0% |
| 1 year | +82.9% | +224.3% |
| Revenue growth (YoY) | +33.7% | +1842.7% |
| Gross margin | 82.2% | 93.3% |
| Net margin | 76.2% | 43.5% |
| P/E (TTM) | 31.4× | 45.7× |
| Price / sales | 21.3× | 14.0× |
| Net cash | $244.1M | $108.1M |
| Dividend yield | — | — |
| Volatility (60d) | 28.5% | 61.2% |
| Short % of float | 13.9% | 18.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).